Evidence map›Paper›PMID 42352205›Full record

ArticleEntropy (Basel, Switzerland)2026

A DNA-Local, Constraint-Aware Dual-Head Transformer for Pseudorandom Stream Generation.

Alev Kaya, İbrahim Türkoğlu

Abstract read
In one paragraph

Article in Entropy (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Alev KayaSoftware Engineering Graduate Program, Graduate School of Natural and Applied Sciences, Firat University, 23119 Elazig, Türkiye.ORCID 0000-0002-3544-5267
İbrahim TürkoğluDepartment of Software Engineering, Faculty of Technology, Firat University, 23119 Elazig, Türkiye.ORCID 0000-0003-4938-4167

Funding

The Scientific and Technological Research Council of Türkiye 123E386
6 · The paper itself

Abstract

Pseudorandom number generators (PRNGs) used in deoxyribonucleic acid (DNA)-oriented computational workflows often generate outputs in the bit domain and then map them to DNA symbols. This indirect strategy may treat DNA-specific constraints, including GC balance, homopolymer limits, and short-range sequence dependencies, as separate from generation. This study proposes a constraint-aware, dual-head decoder-only Transformer framework for DNA-local PRNG generation directly in the adenine/cytosine/guanine/thymine (A/C/G/T) alphabet. The model generates the next DNA base and derives the bitstream through dynamic selection among eight equivalent DNA-to-bit coding rules. The framework was evaluated under R1 based on real genomic data, R1-ext as independent validation, R2 based on synthetic data, and R3 without training or reference data. For each setting, 10 independent runs were performed, each producing a 500,000-base DNA sequence and a 1,000,000-bit stream. Bit-level evaluation used NIST SP 800-22, SP 800-90B-inspired min-entropy/health indicators, and ENT, while DNA-level evaluation used GC balance, homopolymer control, and symbolic structural metrics. The reported NIST tests satisfied the acceptance criterion, t-tuple min-entropy lower bounds ranged from 0.9955 to 0.9964 bit/bit, and core DNA-compatibility constraints were preserved. Multi-stream and exact-match k-mer leakage analyses indicated no systematic bit-level dependence or direct long-fragment copying. Overall, the framework supports reproducible DNA-local PRNG generation and multilayer validation.

Indexed as

adaptive rule selectionconstraint-aware generationDNA-local PRNGdual-head Transformergenomic sequence modelingrandomness evaluation

Identifiers

PMID42352205
PMCPMC13298433

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.